GlobalData on MSN3d
Sanofi and Orano Med link for radioligand therapy developmentSanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation ...
The transaction builds on a three-way partnership between Sanofi, Orano Med, and RadioMedix – signed in September with a €100 ...
Zacks.com on MSN4d
SNY Inks Deal With Orano Med for Next-Generation Radioligand TherapiesSanofi SNY announced that it has entered into an agreement with France-based cancer biotech Orano Med to jointly develop next ...
Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...
Sanofi and Orano Med have announced a new partnership aimed at accelerating the development of next-generation radioligand ...
Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...
Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the ...
Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...
Sanofi and Orano join forces to develop next-generation radioligand medicinesParis, October 17, 2024. Sanofi and Orano Med, a subsidiary of the ...
Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare ...
A month after making a foray into the bustling radioligand field, Sanofi is further allying itself with Orano Med, paying ...
Sanofi & Orano join forces to accelerate the development of develop next-generation radioligand medicines: Paris Friday, October 18, 2024, 10:00 Hrs [IST] Sanofi and Orano Med, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback